Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [41] Post-transplant Outcomes of Patients with End-Stage Renal Disease Caused by Lupus Nephritis
    Eigbire-molen, Odianosen
    Napier, Johnathan
    Coley, Shana
    Caza, Tiffany
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1435 - S1436
  • [42] The Impact of Renal Transplantation on Cardiovascular Events Among Patients with End-State Kidney Disease Due to Lupus Nephritis: A Nationwide Cohort Study
    Jorge, April
    Fu, Xiaoqing
    Zhang, Yuqing
    Choi, Hyon
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [43] Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis
    Pakchotanon, R.
    Gladman, D. D.
    Su, J.
    Urowitz, M. B.
    LUPUS, 2018, 27 (03) : 468 - 474
  • [44] Clinical study of kidney transplantation in diabetic patients with end-stage renal disease
    Sato, S
    Babazono, T
    Tomonaga, O
    Nakamura, M
    Hoshino, T
    Sageshima, J
    Tojimbara, T
    Fujita, S
    Nakajima, I
    Fuchinoue, S
    Teraoka, S
    Agishi, T
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3097 - 3098
  • [45] Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation
    Hage, Fadi G.
    Smalheiser, Stuart
    Zoghbi, Gilbert J.
    Perry, Gilbert J.
    Deierhoi, Mark
    Warnock, David
    Iskandrian, Arni E.
    de Mattos, Angelo M.
    Aqel, Raed A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (06): : 1020 - 1025
  • [46] Kidney transplantation improves arterial stiffness in patients with end-stage renal disease
    Sujuan Feng
    Haozhou Wang
    Jing Yang
    Xiaopeng Hu
    Wei Wang
    Hang Liu
    Han Li
    Xiaodong Zhang
    International Urology and Nephrology, 2020, 52 : 877 - 884
  • [47] Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease
    Beecroft, Jaime M.
    Zaltzman, Jeffrey
    Prasad, Ramesh
    Meliton, Galo
    Hanly, Patrick J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 3028 - 3033
  • [48] Progression of Osteoporosis After Kidney Transplantation in Patients With End-Stage Renal Disease
    Park, W. Y.
    Han, S.
    Choi, B. S.
    Park, C. W.
    Yang, C. W.
    Kim, Y. -S.
    Kim, J. I.
    Moon, I. S.
    Chung, B. H.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (05) : 1033 - 1037
  • [49] Hydration status of patients with end-stage renal disease after kidney transplantation
    Gueutin, Victor
    Ficheux, Maxence
    Chatelet, Valerie
    Lecouf, Angelique
    Henri, Patrick
    de Ligny, Bruno Hurault
    Ryckelynck, Jean-Philippe
    Lobbedez, Thierry
    CLINICAL TRANSPLANTATION, 2011, 25 (06) : E656 - E663
  • [50] Kidney transplantation improves arterial stiffness in patients with end-stage renal disease
    Feng, Sujuan
    Wang, Haozhou
    Yang, Jing
    Hu, Xiaopeng
    Wang, Wei
    Liu, Hang
    Li, Han
    Zhang, Xiaodong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (05) : 877 - 884